Yeji

$KROS

Keros Therapeutics, Inc.

Runway:20+ yrs
NasdaqMarket cap: —CIK 0001664710

Upcoming catalysts

0 surfaced

No catalysts surfaced for KROS yet.

Drug pipeline

KER-047
Iron Deficiency Anemia
Dose A KER-012
Pulmonary Arterial Hypertension
KER-065
Duchenne Muscular Dystrophy

Recent & active trials

NCTDrugPhaseStatusPrimary completion
NCT07704099KER-065Phase 2Not Yet Recruiting2029-07-17
NCT05927012KER-047Phase 2Withdrawn2025-08-29
NCT05975905Dose A KER-012Phase 2Terminated2025-03-05